| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| Mevc Delta Life Sciences Fund I, Inc. |
| 991 Folsom Street, San Francisco, CA 94107 * (877) 474-6382 |
| Business Description | The Company is a newly organized, closed-end investment company. The investment objective is long-term capital appreciation primarily from venture capital, private equity and structured investments in life sciences company, including those focused in the biotechnology, genomic, proteomics, pharmaceuticals, medical devices, drug delivery, diagnostics, predictive medicine and healthcare information technology sectors. |
|
Filing Information Not yet | ||||
| To Trade As | HVC (NYSE) | Industry | Fund (SIC 6726) | |
| Type of Stock Offered | Common Shares | Filing Date | 5/30/00 | |
| Domestic Shares Filed | 5,000,000 | Filing Price | $20.00 | |
| Foreign Shares Filed | 0 | Offering Amount | $100,000,000 | |
| Company Shares | 5,000,000 | Est. Expenses | - - | |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - | |
| Type of fund | Stock | |||
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| UBS Warburg LLC | Lead Manager |
| Use Of Proceeds |
The proceeds from the proposed offering will be used to invest in portfolio companies in accordance with our investment objective and principal strategies and for follow-on investments and future management fees. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Kirkpatrick & Lockhart |
| Bank's Law Firm | Dewey Ballantine |
| Registrar/Transfer Agent | State Street Bank and Trust Company |
| Auditor | Pricewaterhouse Coopers LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |